Attached files
| file | filename |
|---|---|
| EX-10.2 - EXHIBIT 10.2 - Apotheca Biosciences, Inc. | exhibit10-2.htm |
| EX-10.1 - EXHIBIT 10.1 - Apotheca Biosciences, Inc. | exhibit10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2018
CANNABIS LEAF INCORPORATED
(Exact name of registrant as specified in charter)
| Nevada | 000-55467 | 47-2055848 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
4500 9th Avenue NE Seattle, Washington |
98105 |
| (Address of principal executive offices) | (Zip Code) |
(206) 430-6250
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
| 1 |
| Item 1.02 | Termination of a Material Definitive Agreement |
On May 3, 2018 Cannabis Leaf Incorporated (the “Company”) executed a Settlement and Release Agreement (the “Settlement Agreement”) with AGH WA, LLC in order to terminate the License Agreement and cease the business relationship between the Parties, and remedy any defaults of the terms and conditions of the License Agreement.
The compensation pertaining to entering into the Settlement Agreement is an aggregate total of 2,600,000 Restricted Common Shares.
The foregoing description of the Settlement Agreement is qualified in its entirety by reference to the full text of the Settlement Agreement which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference
| Item 8.01 | Other events |
On April 26, 2018, the Company provided a Notice of Termination to Green Venture Capital Inc., Pursuant to the Letter of Intent entered into by the Company and Green Venture Capital, Inc. on October 24, 2017. No Consideration has been paid to date.
ITEM 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 10.1 | Settlement and Release Agreement | |
| 10.2 | Notice of Termination |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CANNABIS LEAF INCORPORATED | |||
| Date: May 4, 2018 | By: | /s/ Jason Sakowski | |
| Jason Sakowski, President & C.E.O. | |||
| 3 |